Apr 29 |
Cullinan Therapeutics appoints CFO
|
Apr 29 |
Cullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financial Officer
|
Apr 27 |
Amgen’s Blincyto data send Cullinan higher
|
Apr 26 |
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
|
Apr 24 |
Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?
|
Apr 24 |
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024
|
Apr 16 |
Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equity
|
Apr 16 |
UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
|
Apr 16 |
Cullinan Therapeutics expands into autoimmune diseases
|
Apr 16 |
Cullinan Therapeutics gets $280M via oversubscribed private placement
|